Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer-Reference-Cited by-同舟云学术

Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer

Published:2019-11-11 Issue:1 Volume:147 Page:107-115
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Beckham Thomas H.¹^ORCID,Barney Christian²³,Healy Erin²,Wolfe Adam R.²,Branstetter Andrew²,Yaney Alexander²,Riaz Nadeem¹,McBride Sean M.¹,Tsai C. Jillian¹,Kang Julie¹,Yu Yao¹,Chen Linda¹,Sherman Eric⁴,Dunn Lara⁴,Pfister David G.⁴,Tan Jeremy⁵,Rupert Robert⁶,Bonomi Marcelo⁶,Zhang Zhigang⁷,Lobaugh Stephanie M.⁷,Grecula John C.²,Mitchell Darrion L.²,Wobb Jessica L.²⁸,Miller Eric D.²,Blakaj Dukagjin M.²,Diavolitsis Virginia M.²⁹,Lee Nancy¹,Bhatt Aashish D.²¹⁰

Affiliation:

1. Department of Radiation OncologyMemorial Sloan Kettering Cancer Center New York NY

2. Department of Radiation OncologyThe Ohio State University Wexner Medical Center Columbus OH

3. Methodist Health System Omaha NE

4. Department of Medical OncologyMemorial Sloan Kettering Cancer Center New York NY

5. Department of BiostatisticsThe Ohio State University Wexner Medical Center Columbus OH

6. Division of Medical OncologyThe Ohio State University Wexner Medical Center Columbus OH

7. Department of BiostatisticsMemorial Sloan Kettering Cancer Center Omaha NE

8. Fort Hamilton Hospital, Kettering Medical Center Hamilton OH

9. Riverside Radiation Oncology, OhioHealth Columbus OH

10. UH Seidman Cancer CenterCase Western Reserve University Cleveland OH

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32736

Reference23 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

2. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

3. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

4. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab

5. Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma: a systematic review;Journal of Cancer Research and Clinical Oncology;2024-08-02

2. Cetuximab in squamous cell carcinoma of the head and neck;Revisiones en Cáncer;2024

3. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer;Head & Neck;2023-07-13

4. Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN);Cancers;2023-06-21

5. Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer;Current Treatment Options in Oncology;2023-04-17